newsfilter
← Latest News
GlobeNewswire·

Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement

Boston (October 10, 2024) — Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that on